webinar tomorrow to hopefully explain and clarify any confusion
this is a great update and confirms nothing has changed, FDA meeting went well and Aus continues to grow... TGA meeting in next quarter now too.
i like this part "“Our positive FDA pre-IND meeting has provided regulatory clarity while unlocking immediate and mid-term commercial
opportunities in the US. As SPONTAN moves through the formal FDA process, Roxus offers a fast-track pathway to serve
patients through personalised care channels"
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $33.58M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.5¢ | $105.7K | 362.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17000 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 407 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |